Genmab A (GNMSF) Current Leases (2023 - 2025)
Historic Current Leases for Genmab A (GNMSF) over the last 3 years, with Q4 2025 value amounting to $18.0 million.
- Genmab A's Current Leases rose 3846.15% to $18.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $18.0 million, marking a year-over-year increase of 3846.15%. This contributed to the annual value of $18.0 million for FY2025, which is 3846.15% up from last year.
- Genmab A's Current Leases amounted to $18.0 million in Q4 2025, which was up 3846.15% from $126.0 million recorded in Q3 2025.
- Over the past 5 years, Genmab A's Current Leases peaked at $132.0 million during Q2 2025, and registered a low of $13.0 million during Q4 2023.
- Over the past 3 years, Genmab A's median Current Leases value was $72.0 million (recorded in 2025), while the average stood at $71.8 million.
- Per our database at Business Quant, Genmab A's Current Leases changed by 0.0% in 2024 and then surged by 3846.15% in 2025.
- Quarter analysis of 3 years shows Genmab A's Current Leases stood at $13.0 million in 2023, then changed by 0.0% to $13.0 million in 2024, then soared by 38.46% to $18.0 million in 2025.
- Its Current Leases was $18.0 million in Q4 2025, compared to $126.0 million in Q3 2025 and $132.0 million in Q2 2025.